Common Contracts
7 similar Licensing Agreement contracts
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
TriLink, QuantiBact ink licensing deal, 7/13:104Licensing Agreement • October 1st, 2021
TriLink BioTechnologies has signed a licensing agreement with QuantiBact to offer twisted intercalating nucleic acid (TINA) modified oligonucleotides.
